Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shyon Parsa

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Molecular Sciences|November 13, 2025
Changes in Apolipoprotein A1-Associated Proteomic Composition After Pioglitazone Treatment Versus Weight LossShyon Parsa, Timothy S Collier, Michael J McPhaul, et al.
Journal of the American Heart Association|March 18, 2026
Association Between Lipoprotein(a) Testing, Lipid-Lowering Therapy Intensification, and Low-Density Lipoprotein Cholesterol Goal Attainment: Findings From the Veterans Affairs Health SystemShyon Parsa, Priyansh Shah, Adam Furst, et al.
Journal of the American College of Cardiology|April 17, 2024
Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the WeekShyon Parsa, Adam Saleh, Viraj Raygor, et al.
American Journal of Preventive Cardiology|April 20, 2026
Artificial intelligence-enabled coronary plaque quantification for personalized risk assessment and lipid-lowering therapy: Insights from the FISH&CHIPS study<sup>✰</sup>Shyon Parsa, Allison W Peng, Jack Bell, et al.
JACC. Heart Failure|August 11, 2023
Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HFMatthew W Segar, Neil Keshvani, Sumitabh Singh, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Molecular Sciences|November 13, 2025
Changes in Apolipoprotein A1-Associated Proteomic Composition After Pioglitazone Treatment Versus Weight LossShyon Parsa, Timothy S Collier, Michael J McPhaul, et al.
Journal of the American Heart Association|March 18, 2026
Association Between Lipoprotein(a) Testing, Lipid-Lowering Therapy Intensification, and Low-Density Lipoprotein Cholesterol Goal Attainment: Findings From the Veterans Affairs Health SystemShyon Parsa, Priyansh Shah, Adam Furst, et al.
Journal of the American College of Cardiology|April 17, 2024
Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the WeekShyon Parsa, Adam Saleh, Viraj Raygor, et al.
American Journal of Preventive Cardiology|April 20, 2026
Artificial intelligence-enabled coronary plaque quantification for personalized risk assessment and lipid-lowering therapy: Insights from the FISH&CHIPS study<sup>✰</sup>Shyon Parsa, Allison W Peng, Jack Bell, et al.
JACC. Heart Failure|August 11, 2023
Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HFMatthew W Segar, Neil Keshvani, Sumitabh Singh, et al.
Pageof 3